- Home
- BNR vs XBP Comparison
BNR vs XBP Comparison
Compare BNR & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- XBP
- Stock Information
- Founded
- BNR 2014
- XBP N/A
- Country
- BNR China
- XBP United Kingdom
- Employees
- BNR N/A
- XBP N/A
- Industry
- BNR Medical Specialities
- XBP Business Services
- Sector
- BNR Health Care
- XBP Consumer Discretionary
- Exchange
- BNR Nasdaq
- XBP Nasdaq
- Market Cap
- BNR 29.1M
- XBP 32.2M
- IPO Year
- BNR 2020
- XBP N/A
- Fundamental
- Price
- BNR $4.22
- XBP $0.92
- Analyst Decision
- BNR
- XBP
- Analyst Count
- BNR 0
- XBP 0
- Target Price
- BNR N/A
- XBP N/A
- AVG Volume (30 Days)
- BNR 29.7K
- XBP 76.5K
- Earning Date
- BNR 08-21-2025
- XBP 08-11-2025
- Dividend Yield
- BNR N/A
- XBP N/A
- EPS Growth
- BNR N/A
- XBP N/A
- EPS
- BNR N/A
- XBP N/A
- Revenue
- BNR $72,112,038.00
- XBP $142,332,000.00
- Revenue This Year
- BNR $136.32
- XBP N/A
- Revenue Next Year
- BNR N/A
- XBP N/A
- P/E Ratio
- BNR N/A
- XBP N/A
- Revenue Growth
- BNR 0.53
- XBP N/A
- 52 Week Low
- BNR $2.18
- XBP $0.79
- 52 Week High
- BNR $7.90
- XBP $1.89
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- XBP 41.85
- Support Level
- BNR $3.06
- XBP $0.81
- Resistance Level
- BNR $3.50
- XBP $0.93
- Average True Range (ATR)
- BNR 0.21
- XBP 0.08
- MACD
- BNR 0.05
- XBP -0.00
- Stochastic Oscillator
- BNR 95.65
- XBP 30.72
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.